by the same cells that release inflammatory mediators (e.g., monocytes, macrophages, T cells). It inhibits the production of inflammatory cytokines such as IL-1, IL-6, and tumor necrosis factor-␣ (TNF-␣) by macrophages stimulated with lipopolysaccharide (LPS) and interferon (14) .
In animal models of sepsis, IL-10 given before or soon after gram-negative bacterial endotoxin reduced TNF-␣ production, hypothermia, and death (17) . It was found that mice treated with anti-IL-10 antibodies are more sensitive to LPS-induced shock (18) and that IL-10-deficient mice developed severe enterocolitis (19) , indicating the essential immunoregulatory role of IL-10. Because of its potent anti-inflammatory effects, IL-10 has been implicated in a number of inflammatory conditions such as sepsis, chronic arthritis, and inflammatory bowel disease.
Nuclear factor-B (NF-B) is a transcription factor that regulates gene transcription of many of the proinflammatory cytokines that are suppressed by IL-10 (3). NF-B is a ubiquitous transcription factor that plays a central role in regulating gene expression of a number of proinflammatory cytokines that are released by activated macrophages (reviewed in Ref. 2) . Thus suppression of NF-B activity is potentially a mechanism for regulating inflammatory responses. NF-B is most frequently composed of two DNA-binding subunits, p50 and p65 (2) , and is present cytoplasmically in an inactive form in resting cells. The nuclear translocation and DNA binding of NF-B dimers is tightly controlled by accessory proteins called IB subunits (3) . NF-B is activated by a diverse range of stimulants, including LPS, ultraviolet light, H 2 O 2 , and inflammatory cytokines such as IL-1 and TNF-␣ (1, 3) . When cells are treated with NF-B inducers, rapid proteolysis of IB-␣ proteins occurs, and NF-B dimers dissociate from the NF-B-IB complex (16, 33) . NF-B inducers cause rapid phosphorylation of IB-␣ on two serine residues (7, 30) after which it is ubiquitinated and finally degraded by the proteosomes (9) . Recently, the IB-␣ kinases (IKK) responsible for the phosphor-ylation have been identified (27) . The release of IB-␣ exposes the nuclear localization sequence of NF-B, and, as a result, NF-B dimers rapidly appear in the nucleus where they bind DNA (2) . A number of genes contain NF-B binding sites that might control their inducible expression (20) . Thus certain genes regulated by NF-B can be transcriptionally activated within minutes after being exposed to the inducer.
The overall goal of this study was to investigate the effect of IL-10 on NF-B activation in macrophages and to elucidate the molecular mechanism involved in this process. Macrophages play an important role in host defense against noxious substances and are involved in a variety of disease processes, including autoimmune diseases, infections, and inflammatory disorders (22) . Although the role of IL-10 as an anti-inflammatory molecule has been well established (21) , the mechanism by which it exerts its action is still not completely understood, and the experimental results are controversial. Whereas most studies have shown that IL-10 inhibits NF-B activation (24, 31) , there are others that report quite the opposite (12, 29) . Similarly, the data on the effect of IL-10 on IB-␣ degradation are contradictory (10, 25) . These differences can be reasonably explained by the fact that IL-10 has a great diversity of action, and the effect of IL-10 on each cell is dependent on many factors, not all of which are understood.
Because macrophages are known to generate reactive oxygen species (ROS) in response to stimuli (23) and because ROS have been implicated as the common messenger involved in NF-B activation by diverse stimuli (5, 6), we hypothesized that IL-10 may exert its effect on NF-B activation by changing the redox status of stimulated cells through an ROS-dependent pathway. The specific questions being addressed in this study are: 1) Do ROS play a role in the IL-10-mediated NF-B signaling pathway? 2) What are the effects of IL-10 on NF-B activation and IB-␣ degradation in macrophages? 3) What are the key reactive species involved in the process? This is the first study that directly demonstrates the inhibitory effect of IL-10 on ROS production.
MATERIALS AND METHODS
Cell culture. The macrophage cell line RAW 264.7 was obtained from the American Type Culture Collection (Manassas, VA). The cells were grown in DMEM (GIBCO BRL, Life Technologies) supplemented with 10% FBS, 2 mM Lglutamine, and 100 U/ml penicillin-streptomycin. Cells were maintained at 37°C in a humidified atmosphere containing 5% CO 2. Before use, cells were trypsinized briefly or scraped mechanically and centrifuged. They were plated at ϳ1 ϫ 10 6 cells/ml in 12-well tissue culture plates 1 day before transfection studies.
Liposomal transfection. Approximately 1 ϫ 10 6 cells were plated on a 12-well plate and allowed to grow for 24 h before the transfection. The plasmid DNA NF-B luciferase (1 g/ ml) was diluted in 200 l of DMEM, and the DNA condensing agent protamine sulfate (1 g/ml; Sigma, St. Louis, MO) was added to the DNA. The liposome (LipofectAMINE, 12 g/ml; GIBCO BRL, Life Technologies) was diluted in 200 l of DMEM. The diluted DNA and liposome samples were combined and incubated at room temperature for 15-20 min. Cells with transfection reagents were incubated for 4 h. Transfection medium was then replaced with growth medium containing 10% FBS. Thirty-six hours after transfection, the cells were stimulated with LPS in either the presence or absence of other test agents. Twelve hours after stimulation, luciferase activity was measured as described below. To account for the potential cytotoxic effect caused by the transfecting agent, LPS, or other test agents during the experiments, total cell protein was determined and used to normalize the measured luciferase activity. All transfections were conducted under sterile conditions, and duplicate plates were tested for each condition.
Stable transfection. Cells were transfected with 1 g of both CMV-mIL-10 (a kind gift from Dr. H. Tahara, University of Pittsburgh) and pCDNA 3 with the protocol above for transient transfection. Two days after transfection, the medium was replaced with fresh complete medium containing 20 l of 75 g/ml G418 solution. Every 2 days, the medium was changed, and fresh G418 was added; this was cultured for 2 wk. Survived colonies were picked and tested for their ability to produce IL-10 as determined by ELISA. To ensure a homogeneous population of cells, positive colonies were subcloned and rescreened. The control cell line (RAW control) was prepared the same way except that a control CMV plasmid lacking IL-10 was used.
Measurement of luciferase activity. Luciferase synthesized during the in vitro translation was quantitated by the assay of enzyme-dependent light production using a luciferase assay kit (Promega, Madison, WI). Cells were washed two times with PBS and incubated at room temperature for 10 min in the presence of 250 l of lysis buffer (Promega) and then centrifuged at 12,000 g. Ten microliters of each sample were placed in a 5-ml polystyrene test tube, and the tubes were then loaded in an automated luminometer (Bio-Rad, Hercules, CA). At the time of measurement, 100 l of luciferase substrate were injected automatically in each sample, and total luminescence was measured over a 20-s time interval. Output is quantitated as relative light units. Protein content in the supernatant was determined by the bicinchoninic acid (BCA) protein assay reagent (Pierce, Rockford, IL). Luminescence detected was standardized per microgram protein present in the supernatant.
Determination of TNF-␣ protein.
In experiments where inhibition of TNF-␣ produced by LPS stimulation had to be studied, cells were stimulated with the indicated amount of LPS for 6 h at 37°C. Cell-free supernatants were then collected and assayed for cytokines by ELISA kits specific for murine TNF-␣, and protein levels were measured as specified by the manufacturer (Endogen). The sensitivity of the assays ranged from 15 to 31 pg/ml. The coefficient of variation for all cytokine assays was Ͻ10%.
Oligonucleotides. Oligonucleotides (ON) were purchased from GIBCO BRL, Life Technologies. The synthesized singlestrand ON were deprotected and desalted, and complementary strands were denatured at 80°C for 5 min and annealed at room temperature. The double-strand ON were labeled with [
32 P]dCTP (Amersham, Arlington Heights, IL) by using Klenow fragment (Bethesda Research Laboratories, Gaithersburg, MD), and the labeled ON were used as probes in the electrophoretic mobility shift assay (EMSA). The ON used in this study contained the NF-B sequence of the IL-6 gene promoter (74-TGGGATTTTCCCATGAGTCT-54).
Nuclear extraction. Nuclear extracts were prepared as follows: 5 ϫ 10 7 cells were treated with 500 l of lysis buffer [50 mM KCl, 0.5% Nonidet P-40, 25 mM HEPES, 1 mM phenylmethylsulfonyl fluoride (PMSF), 10 g/ml leupeptin, 20 g/ml aprotinin, and 100 M dithiothreitol (DTT)] and kept on ice for 4 min. Nuclei were pelleted by centrifugation at 20,000 rpm for 1 min, and supernatants were discarded. The nuclei were washed one time with the same buffer without Nonidet P-40, and the nuclei were extracted in 300 l of extraction buffer (500 mM KCl, 10% glycerol, 25 mM HEPES, 1 mM PMSF, 10 g/ml leupeptin, 20 g/ml aprotinin, and 100 M DTT). After centrifugation at 20,000 rpm for 5 min, the supernatants were harvested. The protein concentration of the resulting nuclear protein extract was determined by BCA protein assay reagent (Pierce) , and the samples were diluted to 1 g/l with extraction buffer. The nuclear proteins were stored at Ϫ70°C.
EMSA. The DNA-protein binding reaction was conducted in a 24-l reaction mixture including 3 g of nuclear protein extract, 1 g of poly(dI ⅐ dC) (Sigma), 3 g of BSA, and 12 l of 2xY buffer, which contained 24% glycerol, 24 mM HEPES, 8 mM Tris ⅐ HCl, 2 mM EDTA, and 2 mM 1,4-dithiothreitol. The mixture was incubated on ice for 10 min. A total of 10 5 counts/min of 32 P-labeled ON probe was added, and the mixture was incubated for an additional 20 min at room temperature and then loaded on a 5% acrylamide gel (GIBCO BRL) that had been prerun at 110 volts for 30 min with 0.5ϫ Tris-borate-EDTA buffer. The loaded gel was run at 200 V for 90 min and then was dried and exposed to X-OMAT film overnight (Eastman Kodak, Rochester, NY) for autoradiography. The film was developed after overnight exposure at Ϫ70°C.
Western blots. For intracellular IB-␣ degradation studies, whole cell proteins were extracted. Whole cell extracts were subjected to 12% SDS-PAGE. Resolved proteins were transferred to a nitrocellulose membrane and incubated with affinity-purified rabbit polyclonal anti-IB-␣ serum raised against a peptide corresponding to amino acids 297-317 (mapping within the carboxy-terminal domain of the human IB-␣ molecule). After three 10-min washes with PBS-Tween 20, the membranes were incubated with peroxidase-conjugated anti-rabbit immunoglobulin, and the antigen-antibody complexes were detected using enhanced chemiluminescence Western blotting detection reagents according to the manufacturer's instructions.
Free radical measurements. The electron spin resistance (ESR) spin-trapping technique was used to detect short-lived free radical intermediates (32) . Spin trapping is necessary because of the reactive nature of the free radicals to be studied. This technique involves an addition-type reaction of a short-lived radical with a diamagnetic compound (spin trap) to form a relatively long-lived free radical product, the so-called spin adduct, which can be studied by conventional ESR. The intensity of the spin adduct signal corresponds to the amount of short-lived radicals trapped, and the hyperfine splittings of the spin adduct are generally characteristic of the original, short-lived, trapped radical.
All measurements were conducted with a Varian E9 ESR spectrometer and a flat-cell assembly. Hyperfine splittings were measured (to 0.1 G) directly from magnetic field separations using potassium tetraperoxochromate and 1,1-diphenyl-2-picrylhydrazyl as standards. Reactants were mixed in test tubes in a total volume of 0.5 ml. The reaction mixture was then transferred to a flat cell for ESR measurement. All measurements were carried out using 5,5-dimethyl-1-pyrroline-N-oxide (DMPO; Aldrich) as a spin trap.
Oxygen consumption measurements. Oxygen consumption measurements were carried out with a Gilson oxygraph equipped with a Clark electrode (Gilson Medical Electronics, Middleton, WI). These measurements were made from mixtures containing 1.0 ϫ 10 6 cells/ml and various treatments in a total volume of 1.5 ml. The oxygraph was calibrated with media equilibrated with oxygen of known concentrations.
Statistical analysis. Each study group consisted of four experiments. Statistical analysis between study groups was performed with paired two-tailed Student's t-test. The level of significance was P Ͻ 0.05. 10 . It has been suggested that NF-B mediates the transcriptional activation of TNF-␣ (2). We tested whether IL-10 could inhibit NF-B-dependent TNF-␣ expression. RAW 264.7 macrophages were stimulated with LPS (10 ng/ml) for 6 h, and cell culture supernatants were then assayed by ELISA for TNF-␣ released. Stimulation of cells with LPS resulted in the release of high concentrations of TNF-␣. Pretreatment of cells with recombinant mouse IL-10 (1-50 ng/ml) 2 h before stimulation with LPS (10 ng/ml) resulted in a dosedependent inhibition (50-72%) in TNF-␣ production (Fig. 1A) . We also tested the inhibitory effect of IL-10 on TNF-␣ production in a stably transfected cell line (RAW IL-10) that constitutively expresses IL-10 protein. Stimulation of RAW IL-10 with LPS showed much lower levels of TNF-␣ compared with the regular (RAW 264.7) or control cell line (RAW control; Fig. 1B) .
RESULTS

Inhibition of LPS-induced TNF-␣ production by IL-
Effect of IL-10 on NF-B binding activity and IB-␣ degradation.
EMSA studies were performed on stably transfected cells to study the effect of IL-10 on NF-B Fig. 1 . Inhibition of tumor necrosis factor-␣ (TNF-␣) production by interleukin (IL)-10. A: RAW 264.7 cells (10 6 /ml) were pretreated with varying concentrations of recombinant mouse IL-10 (1-50 ng/ml) for 2 h at 37°C, after which they were treated with lipopolysaccharide (LPS, 0.1 g/ml) for 6 h at 37°C. The supernatants were collected at the end of 6 h and assayed for TNF-␣ by ELISA. B: two stable cell lines were generated. RAW IL-10 was stably transfected with IL-10-containing plasmid, and RAW control was transfected with control plasmid. The cells (10 6 /ml) were stimulated with LPS (0.1 g/ml) for 6 h at 37°C after which the supernatants were collected and assayed for TNF-␣ by ELISA. Values are means Ϯ SD; n ϭ 4 experiments. *Significant decrease from LPS-treated control (P Ͻ 0.05). activation (Fig. 2) . Although LPS stimulation enhances NF-B binding activity of RAW 264.7 and RAW control cells, this LPS-induced NF-B activity was inhibited in the RAW IL-10 cell line. This suggests that IL-10 is responsible for NF-B inhibition.
To determine if IL-10 inhibited the transcriptional activation of NF-B, RAW 264.7 cells were transiently transfected with an expression plasmid containing luciferase gene transcribed from the NF-B-dependent promoter. The transfected cells were treated with LPS in the presence or absence of IL-10. Figure 3A shows that LPS treatment caused a 10-fold increase in luciferase activity that was inhibited by IL-10 in a dosedependent manner. These data suggest that IL-10 not only prevents NF-B-DNA binding but also inhibits NF-B-induced transcription and hence gene expression.
Because the activity of NF-B is controlled by its interaction with IB-␣, the next logical step would be to test if IL-10 inhibits NF-B activation via its effect on IB-␣ degradation. To determine if the decreased DNA binding activity of NF-B is due to inhibition of IB-␣ proteolysis, we performed Western blot analysis on either RAW control or RAW IL-10 cells stimulated with LPS (Fig. 3B) . Cell lysates were collected, and immunoblotting for IB-␣ was performed. In the control cell line, LPS stimulation caused complete proteolysis of IB-␣ by 30 min. RAW control cells behave very similarly to regular RAW 264.7 cells. This degradation of IB-␣ is not seen in LPS-stimulated RAW IL-10 cells. These results suggest that IL-10 inhibits IB-␣ degradation.
Role of ROS in LPS-stimulated macrophages. The role of free radical reactions in LPS-induced NF-B activation was examined using specific ROS inhibitors, including superoxide dismutase (SOD; O 2 Ϫ scavenger), catalase (H 2 O 2 scavenger), and sodium formate (⅐OH scavenger). Macrophages are known to generate free radicals in response to stimuli (23) . O 2 Ϫ ⅐, H 2 O 2 , and ⅐OH are three major reactive species produced by macrophages (13, 15) and thus are the primary focus of our investigation. As shown in Fig. 4A , cells treated with catalase and sodium formate before LPS stimulation exhibited a decrease in NF-B activity, whereas SOD pretreatment had no effect on LPS-induced NF-B activity. It should be noted that all three scavengers were tested at different concentrations; however, only optimal concentrations of each scavenger are presented here.
Western blots were employed to determine if these ROS scavengers inhibited NF-B activation as a result of the stabilization of IB-␣. RAW 264.7 cells were treated with the same specific ROS scavengers SOD, catalase, and sodium formate before stimulation with LPS. Consistent with the results above, addition of catalase and sodium formate inhibited LPS-induced IB-␣ degradation while SOD was not effective (Fig.  4B) . It must be noted that pretreatment of cells with IL-10 also inhibited IB-␣ degradation (Fig. 4B) .
The results obtained above suggest that ROS are involved in the process and that H 2 O 2 and ⅐OH play a major role. Because H 2 O 2 has been reported to be a major source of ⅐OH formation in macrophages, i.e., via the metal-catalyzed Fenton reaction [
where M is the metal and n is the valence] (23), and because ⅐OH is known to be highly reactive, we suggest that ⅐OH may be the primary oxidative species responsible for the observed effects induced by LPS. Supporting this notion is the fact that sodium formate was equally effective as catalase in inhibiting NF-B activity and IB-␣ degradation.
Effect of IL-10 on hydroxyl radical generation. Our results suggest that ⅐OH radical may be the key species involved in NF-B activation. To confirm that ⅐OH radicals were actually formed during LPS activation, ESR studies using the spin trap DMPO were carried out. ESR spin trapping is a method that is specific and sensitive and is considered to be the best technique for detection and identification of free radical generation (32) . Cells were treated with LPS in the presence or absence of IL-10 and ROS scavengers. Figure 5 shows that, in the presence of LPS, an ESR spectrum consisting of a 1:2:2:1 quartet pattern, which is characteristic of the DMPO-⅐OH adduct (8), was observed. LPS-induced adduct formation increased with time and reached a peak in 1 h. Pretreatment of cells with IL-10 inhibited LPS-induced free radical generation (Fig. 5) . Pretreatment with a control protein, albumin, did not have any inhibitory effect on LPS-induced ⅐OH generation. Addition of the ⅐OH scavenger sodium formate to the system decreased the intensity of the DMPO-⅐OH signal, thus confirming the formation of ⅐OH induced by LPS. Interestingly, catalase, the function of which is to scavenge H 2 O 2 , also inhibited ⅐OH formation. These results are consistent with previous studies by our group that demonstrated that H 2 O 2 can react with endogenous metal ions to form ⅐OH via the Fenton After transfection (36 h), the cells were pretreated with the different oxygen radical scavengers, superoxide dismutase (SOD, 500 U/ml), catalase (500 U/ml), and sodium formate (5 mM) for 4 h before stimulation with LPS (0.1 g/ml) for 12 h at 37°C. Luciferase activity was then measured by luminescence. B: Western blots were performed to determine the effect of reactive oxygen species (ROS) on IB-␣. RAW 264.7 cells (10 6 /ml) were pretreated with the different ROS scavengers, SOD (500 U/ml), catalase (500 U/ml), and sodium formate (5 mM) for 4 h before stimulation with LPS (0.1 g/ml) for the different time points. Values are means Ϯ SD; n ϭ 4 experiments. *Significant decrease from LPS-treated control (P Ͻ 0.05). All experiments were repeated 4 times, and a representative gel is shown.
reaction (23) . It is interesting to note that, when IL-10 was added to a chemical system (Fenton reaction), it did not inhibit ⅐OH generation. These results suggest that IL-10 is not a free radical scavenger. Instead, it interacts with the cellular machinery in such a way that free radical production is inhibited. Oxygen consumption studies also showed that IL-10 was able to inhibit molecular oxygen consumption in LPS-stimulated RAW 264.7 cells (Fig. 6) .
DISCUSSION
IL-10 is an anti-inflammatory cytokine that plays an important regulatory role in inflammatory diseases (11, 21) . Studies with IL-10 knockout mice have shown that a key function of IL-10 is the control of inflammatory responses (19) . In vitro and in vivo studies suggest that IL-10 could be a potentially useful therapeutic agent for the treatment of acute and chronic, systemic and localized inflammatory reactions.
Although numerous studies have been performed to identify the signaling pathways targeted by IL-10, the mechanism is still not completely understood. We hypothesized that IL-10 mediates part of its inhibitory effects via its effect on ROS. Our studies show that IL-10 pretreatment inhibits TNF-␣ production of stimulated macrophages because of its ability to decrease NF-B-DNA binding and NF-B-induced transcription. Further analysis showed that IL-10 inhibits LPSinduced IB-␣ degradation.
Macrophages provide an important line of host defense against noxious substances. One of the essential mechanisms by which this is accomplished is the production of reactive oxygen metabolites such as O 2 Ϫ ⅐ and H 2 O 2 through the respiratory burst. Excessive production of these oxidative species, however, can also cause toxic reactions to the cell and potentiate several pathological conditions. It has been suggested that the highly reactive ⅐OH, which is generated from H 2 O 2 via the iron-mediated Fenton reactions, is the major oxidant species that causes cellular injury (23) . ⅐OH radicals are known to induce lipid peroxidation, which causes damage to the cell membrane.
NF-B inducers produce ROS (2) , and the observation that antioxidants and radical scavengers inhibit the activation of NF-B strongly supports the idea that oxygen radicals are involved in the release of IB-␣ from the NF-B-IB complex. Recent studies have indicated that ROS can activate a number of cytokine genes, including the TNF-␣ gene. It has also been speculated that the protease activities involved with IB-␣ are under the control of the cell's redox status (2) . This speculation is strengthened by the observation that the antioxidant pyrrolidone dithiocarbamate prevents inducible decay of IB-␣ in response to phorbol 12-myristate 13-acetate (4, 16, 28) .
Oxygen free radicals are known to facilitate the progress of inflammatory reactions. Because NF-B has been identified as an oxidative stress-responsive transcription factor that is activated by a diverse range of inducers, it has been postulated that ROS may be the common messenger involved in the signal transduction pathway leading to NF-B activation (2) . Our results show that ROS are involved in NF-B activation and IB-␣ degradation. Specifically, ⅐OH seems to be the key player in ROS-mediated IB-␣ degradation. ⅐OH radicals in macrophages are generated via the Because IL-10 inhibits IB-␣ degradation, we tested the effect of IL-10 on ⅐OH radical generation. IL-10 inhibits LPS-induced ⅐OH radical generation, as demonstrated by ESR. The fact that IL-10 does not inhibit ⅐OH radicals in a chemical system suggests that IL-10 does not act as a free radical scavenger. Instead, it probably induces signals that interface with the cellular signals that generate ROS in response to LPS stimulation. The results of oxygen consumption studies further suggest that IL-10 inhibits cellular production of ROS by reducing molecular oxygen consumption induced by LPS. A recent study by Schottelius et al. (25) has shown that IL-10 inhibits TNF-␣-induced activation of IKK, which is responsible for phosphorylation and subsequent degradation of IB-␣. Bonizzi et al. (5) have suggested that ROS generation may be required for cell-specific kinase activity. It is interesting to note that, when IL-10 was added to a chemical system (Fenton reaction), it did not inhibit ⅐OH generation. These results suggest that IL-10 is not a free radical scavenger. Instead, it interacts with the cellular machinery in such a way that free radical production is inhibited. Based on our results and those reported earlier, we propose the following mechanism of action for IL-10. IL-10 inhibits ROS production, which in turn inhibits IKK activity and hence IB-␣ degradation. This results in a decrease in NF-B activity and hence decreases the expression of inflammatory cytokines such as TNF-␣. This whole cascade of events is responsible for the anti-inflammatory properties of IL-10 in macrophages. Although the proposed mechanism is in line with the evidence shown here, the linkage between LPS, free radicals, and IL-10 is still not completely understood. Although we have shown that IL-10 inhibits LPS-induced free radical generation, the exact pathway is still not clear, and further studies are being done.
In conclusion, IL-10 inactivates macrophage production of reactive oxygen radicals, thereby decreasing inflammation. The results in this study provide a new light into the action of IL-10. Finally, the mechanism of IL-10 in this cell type may not be reflective of its action in other cell types. As rightly discussed by Bowie and O'Neill (6), signal transduction pathways in different cell types need to be addressed individually.
